Delivery Order SPE2DB22D2006-SPE2DB25FW0CF

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $79K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.53, is for the supply of 4,568,060,823 units of the drug Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for this...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,635.62, is for the delivery of 4,567,956,493 units of the medication Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug Corp is a for-profit organization that...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,351.98, is for the delivery of Valsartan-HCTZ 320-25 mg tablets. The contract has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,887.52 contract is for the supply of 4,568,092,529 units of the medication Valsartan-HCTZ 320-25 mg tablets. The award is not set aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a $17,976.09 firm-fixed-price delivery order contract for 4,563,079,908 units of the drug Valsartan-HCTZ 320-25 mg tablets. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $4,450.69, is for the delivery of 4,563,926,962 units of the pharmaceutical product Valsartan-HCTZ 320-25 mg Tablets, with a period of performance through March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $3,615.46 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Valsartan-HCTZ 160-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,790.15 contract is for the supply of 4,565,304,801 units of the pharmaceutical product Valsartan-HCTZ 320-12.5 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,451.77, is for the supply of 4,564,885,021 units of the drug Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract has a firm fixed price and an ultimate completion date of June 13, 2024. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0CF
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $78,569.44, is for the delivery of 4,567,957,165 units of the medication Valsartan-HCTZ 320-25 mg tablets in 90-count packages. The contract has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp is a for-profit organization and a critical supplier of medical and pharmaceutical products to federal agencies, particularly the military healthcare system. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 7/17/25, 2:32 PM